Literature DB >> 7906169

Multidrug resistance in cancer.

D R Ferry, D J Kerr.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7906169      PMCID: PMC2542514          DOI: 10.1136/bmj.308.6922.148

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  18 in total

Review 1.  Is the multidrug transporter a flippase?

Authors:  C F Higgins; M M Gottesman
Journal:  Trends Biochem Sci       Date:  1992-01       Impact factor: 13.807

2.  Expression of a multidrug-resistance gene in human tumors and tissues.

Authors:  A T Fojo; K Ueda; D J Slamon; D G Poplack; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

3.  Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins.

Authors:  P Gros; J Croop; D Housman
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

4.  Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies.

Authors:  J L Biedler; H Riehm
Journal:  Cancer Res       Date:  1970-04       Impact factor: 12.701

Review 5.  Biochemistry of multidrug resistance mediated by the multidrug transporter.

Authors:  M M Gottesman; I Pastan
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

6.  Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability.

Authors:  J R Riordan; V Ling
Journal:  J Biol Chem       Date:  1979-12-25       Impact factor: 5.157

7.  Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.

Authors:  T Tsuruo; H Iida; Y Kitatani; K Yokota; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

8.  Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON.

Authors:  P Sonneveld; B G Durie; H M Lokhorst; J P Marie; G Solbu; S Suciu; R Zittoun; B Löwenberg; K Nooter
Journal:  Lancet       Date:  1992-08-01       Impact factor: 79.321

9.  P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding site.

Authors:  D R Ferry; M A Russell; M H Cullen
Journal:  Biochem Biophys Res Commun       Date:  1992-10-15       Impact factor: 3.575

10.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.

Authors:  S P Cole; G Bhardwaj; J H Gerlach; J E Mackie; C E Grant; K C Almquist; A J Stewart; E U Kurz; A M Duncan; R G Deeley
Journal:  Science       Date:  1992-12-04       Impact factor: 47.728

View more
  4 in total

1.  Resistance mechanisms of cancer cells to the novel vacuolar H(+)-ATPase inhibitor archazolid B.

Authors:  Rebecca Hamm; Yoshikazu Sugimoto; Heinrich Steinmetz; Thomas Efferth
Journal:  Invest New Drugs       Date:  2014-07-29       Impact factor: 3.850

2.  Partial circumvention of P-glycoprotein-mediated multidrug resistance by doxorubicin-14-O-hemiadipate.

Authors:  Olga V Leontieva; Maria N Preobrazhenskaya; Ralph J Bernacki
Journal:  Invest New Drugs       Date:  2002-02       Impact factor: 3.850

Review 3.  Guidelines, enthusiasms, uncertainty, and the limits to purchasing.

Authors:  M McKee; A Clarke
Journal:  BMJ       Date:  1995-01-14

4.  Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer.

Authors:  S J Darnton; K Jenner; R S Steyn; D R Ferry; H R Matthews
Journal:  J Clin Pathol       Date:  1995-11       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.